Showing 221 - 240 results of 506 for search '"respiratory disease"', query time: 0.12s Refine Results
  1. 221

    Social determinants of the healthcare needs of undocumented migrants living with non-communicable diseases: a scoping review by Claudine Burton-Jeangros, Yves Jackson, Janeth Tenorio-Mucha, Corinne Jeffries-Tolksdorf, Jan-Erik Refle

    Published 2024-07-01
    “…Objectives We aimed to map the social determinants of meeting the healthcare needs of undocumented migrants living with non-communicable diseases (NCDs) throughout their migration journey (from the country of origin to the country(/ies) of transit and destination).Design We conducted a scoping review.Data sources We searched literature in Medline, Embase, Web of Science and Google Scholar.Eligibility criteria We included articles that describe interventions, programmes or policies for undocumented migrants living with cardiovascular diseases, cancer, chronic respiratory disease, or diabetes. There were no restrictions by setting (eg, hospital, community or mobile clinic) or country. …”
    Get full text
    Article
  2. 222
  3. 223

    Comparative Genomics Analysis of Two Different Virulent Bovine Pasteurella multocida Isolates by Huihui Du, Rendong Fang, Tingting Pan, Tian Li, Nengzhang Li, Qiang He, Rui Wu, Yuanyi Peng, Zeyang Zhou

    Published 2016-01-01
    “…The Pasteurella multocida capsular type A isolates can cause pneumonia and bovine respiratory disease (BRD). In this study, comparative genomics analysis was carried out to identify the virulence genes in two different virulent P. multocida capsular type A isolates (high virulent PmCQ2 and low virulent PmCQ6). …”
    Get full text
    Article
  4. 224

    Isolation and study of biological properties of <i>Bordetella bronchiseptica</i>-specific bacteriophages by T. A. Kochetova, V. V. Yuskevich, G. T. Sadykova, V. M. Popova

    Published 2022-09-01
    “…Three new bacteriophages were recovered from clinical material of animals with respiratory disease signs: vB_BbrS_2/200220.7.2, vB_BbrS_4/200220.7.1, vB_BbrM_5/200220.7.2. …”
    Get full text
    Article
  5. 225

    Covid 19 and beyond: a procedure for HVAC systems to address infectious aerosol illness transmission by Douglas Stuart Walkinshaw, Raymond Henry Horstman

    Published 2023-07-01
    “…Given that infectious aerosols released from the breath of occupants were practically an unknown vector of respiratory disease in the healthcare community for many decades, understandably HVAC regulations have not addressed this issue yet. …”
    Get full text
    Article
  6. 226
  7. 227

    Lumbar Spinal Stenosis Has a Negative Impact on Quality of Life Compared with Other Comorbidities: An Epidemiological Cross-Sectional Study of 1862 Community-Dwelling Individuals by Koji Otani, Shinichi Kikuchi, Shoji Yabuki, Tamaki Igarashi, Takuya Nikaido, Kazuyuki Watanabe, Shinichi Konno

    Published 2013-01-01
    “…In addition, the presence of comorbid conditions that affect QoL, such as osteoarthritis of the knee and hip, cardiovascular disease, cerebrovascular disease, or respiratory disease, was also analyzed. The prevalence of symptomatic LSS gradually increased with age. …”
    Get full text
    Article
  8. 228

    Association between the triglyceride glucose body mass index and asthma: evidence from NHANES 2011–2018 by Sijia Yu, Shiping Wu, Shouxin Wei

    Published 2025-01-01
    “…Abstract Background Asthma is a common chronic respiratory disease whose increasing prevalence poses a significant burden to human health and the economy. …”
    Get full text
    Article
  9. 229

    The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients by Faisal A. Alzahrani, Islam M. Saadeldin, Abrar Ahmad, Dipak Kumar, Esam I. Azhar, Arif Jamal Siddiqui, Bassem Kurdi, Abdulrahim Sajini, Abdulmajeed F. Alrefaei, Sadaf Jahan

    Published 2020-01-01
    “…A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) causing lethal acute respiratory disease emerged in December 2019. The World Health Organization named this disease “COVID-19” and declared it a pandemic on March 11, 2020. …”
    Get full text
    Article
  10. 230

    Improving influenza vaccine uptake in clinical risk groups: patient, provider and commissioner perspectives on the acceptability and feasibility of expanding delivery pathways in E... by Sandra Mounier-Jack, Rajeka Lazarus, Ben Kasstan, Ifra Ali

    Published 2024-05-01
    “…Phase I involved 32 semi-structured interviews conducted with individuals from three clinical risk groups: diabetes, chronic liver disease or chronic respiratory disease (or comorbidities). Phase II consisted of semi-structured interviews with 50 healthcare providers based in National Health Service primary and secondary care settings, and influenza vaccine commissioners and programme managers. …”
    Get full text
    Article
  11. 231
  12. 232

    Impact of extreme heat on health in Australia: a scoping review by Patrick Amoatey, Zhiwei Xu, Chinonso Christian Odebeatu, Neha Singh, Nicholas J. Osborne, Dung Phung

    Published 2025-02-01
    “…Heat-associated ambulance callouts was prominent for patients with cardiovascular and respiratory diseases. This evidence suggests that these heat-related diseases should be used as health indicators for developing and validating HVI in Australia. …”
    Get full text
    Article
  13. 233
  14. 234

    The Epidemiology of Pulmonary Nontuberculous Mycobacteria: Data from a General Hospital in Athens, Greece, 2007–2013 by Marios Panagiotou, Andriana I. Papaioannou, Konstantinos Kostikas, Maria Paraskeua, Ekaterini Velentza, Maria Kanellopoulou, Vasiliki Filaditaki, Napoleon Karagiannidis

    Published 2014-01-01
    “…NTM infection is common in patients with chronic respiratory disease. However, only a significantly smaller proportion of patients fulfill the criteria for NTM disease.…”
    Get full text
    Article
  15. 235

    Machine learning potential predictor of idiopathic pulmonary fibrosis by Chenchun Ding, Quan Liao, Renjie Zuo, Shichao Zhang, Zhenzhen Guo, Junjie He, Ziwei Ye, Weibin Chen, Sunkui Ke

    Published 2025-01-01
    “…IntroductionIdiopathic pulmonary fibrosis (IPF) is a severe chronic respiratory disease characterized by treatment challenges and poor prognosis. …”
    Get full text
    Article
  16. 236

    Remission: does it already exist in chronic rhinosinusitis with nasal polyposis? by Yvonne Chan, Andrew V. Thamboo, Joseph K. Han, Martin Desrosiers

    Published 2023-07-01
    “…For CRSwNP patients with co-morbidities such as asthma and aspirin exacerbated respiratory disease, remission rate drops to 23% and 23.5%, respectively compared to non-asthmatic CRSwNP patients who present a remission rate under continued medical therapy of 60%. …”
    Get full text
    Article
  17. 237

    Qingfei Tongluo Mixture Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis through mTOR-Dependent Autophagy in Rats by Shuyu Ge, Zhenghong Guo, Ting Xiao, Pingping Sun, Bo Yang, Yin Ying

    Published 2024-01-01
    “…A hospital preparation used for the treatment of viral pneumonia, Qingfei Tongluo mixture (QFTL), is rumored to have protective effects against inflammatory and respiratory disease. This study aims to confirm whether it has a therapeutic effect on bleomycin-induced IPF in rats and to elucidate its mechanism of action. …”
    Get full text
    Article
  18. 238

    Retrospective Analysis of RSV Infection in Pediatric Patients: Epidemiology, Comorbidities, Treatment, and Costs in Dubai (2014-2023) by Jean Joury, Nawal Al Kaabi, Sara Al Dallal, Bassam Mahboub, Mostafa Zayed, Mohamed Abdelaziz, Jennifer Onwumeh-Okwundu, Mark A. Fletcher, Subramanyam Kumaresan, Badarinath C. Ramachandrachar, Mohamed Farghaly

    Published 2024-11-01
    “…In Cohort 1, 32.0% had upper respiratory tract infections, 39.4% had lower respiratory tract infections, and 44.4% of patients had an “other respiratory disease.” The average length of hospitalization was about 4 days across all cohorts. …”
    Get full text
    Article
  19. 239

    The spatial and temporal pattern of COVID-19 and its effect on humans’ development in China by X. Xie, E. Naminse, S. Liu, Q. Yi

    Published 2020-06-01
    “…The coronavirus disease 2019 (COVID-19) has been identified as the main cause of the outbreak of the respiratory disease in Wuhan, Hubei Province of China in December 2019. …”
    Get full text
    Article
  20. 240

    Shared Bacterial and Viral Respiratory Agents in Bighorn Sheep (Ovis canadensis), Domestic Sheep (Ovis aries), and Goats (Capra hircus) in Montana by David S. Miller, Glen C. Weiser, Keith Aune, Brent Roeder, Mark Atkinson, Neil Anderson, Thomas J. Roffe, Kim A. Keating, Phillip L. Chapman, Cleon Kimberling, Jack Rhyan, P. Ryan Clarke

    Published 2011-01-01
    “…Transmission of infectious agents from livestock reservoirs has been hypothesized to cause respiratory disease outbreaks in bighorn sheep (Ovis canadensis), and land management policies intended to limit this transmission have proven controversial. …”
    Get full text
    Article